athenahealth, Inc. (NASDAQ:ATHN) SVP Jonathan D. Porter sold 300 shares of the stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $142.88, for a total value of $42,864.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Jonathan D. Porter also recently made the following trade(s):

  • On Friday, July 21st, Jonathan D. Porter sold 422 shares of athenahealth stock. The stock was sold at an average price of $154.00, for a total value of $64,988.00.
  • On Monday, July 17th, Jonathan D. Porter sold 300 shares of athenahealth stock. The stock was sold at an average price of $143.13, for a total value of $42,939.00.
  • On Thursday, June 15th, Jonathan D. Porter sold 300 shares of athenahealth stock. The stock was sold at an average price of $142.27, for a total value of $42,681.00.

athenahealth, Inc. (NASDAQ ATHN) traded up 1.17% during trading on Wednesday, hitting $144.18. The stock had a trading volume of 193,249 shares. The company’s 50 day moving average is $142.53 and its 200 day moving average is $125.93. athenahealth, Inc. has a 52-week low of $90.11 and a 52-week high of $158.66. The firm has a market cap of $5.76 billion, a PE ratio of 182.97 and a beta of 1.77.

athenahealth (NASDAQ:ATHN) last issued its quarterly earnings results on Thursday, July 20th. The health services provider reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.39 by $0.12. The business had revenue of $301.10 million for the quarter, compared to the consensus estimate of $298.68 million. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. The business’s quarterly revenue was up 15.0% on a year-over-year basis. During the same period in the prior year, the firm posted $0.34 earnings per share. Equities research analysts forecast that athenahealth, Inc. will post $1.91 earnings per share for the current year.

WARNING: This story was first posted by American Banking News and is the property of of American Banking News. If you are accessing this story on another publication, it was copied illegally and reposted in violation of international copyright laws. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/08/16/athenahealth-inc-athn-svp-sells-42864-00-in-stock.html.

Several institutional investors have recently added to or reduced their stakes in the stock. Wells Fargo & Company MN increased its position in athenahealth by 5.0% in the first quarter. Wells Fargo & Company MN now owns 83,679 shares of the health services provider’s stock valued at $9,430,000 after buying an additional 3,995 shares during the last quarter. Rockefeller Financial Services Inc. increased its position in athenahealth by 13.1% in the first quarter. Rockefeller Financial Services Inc. now owns 8,445 shares of the health services provider’s stock valued at $952,000 after buying an additional 975 shares during the last quarter. Sumitomo Mitsui Asset Management Company LTD increased its position in athenahealth by 37.0% in the first quarter. Sumitomo Mitsui Asset Management Company LTD now owns 391,965 shares of the health services provider’s stock valued at $44,170,000 after buying an additional 105,910 shares during the last quarter. Wesbanco Bank Inc. purchased a new position in athenahealth during the first quarter valued at about $714,000. Finally, Russell Investments Group Ltd. increased its position in athenahealth by 380.8% in the first quarter. Russell Investments Group Ltd. now owns 5,409 shares of the health services provider’s stock valued at $609,000 after buying an additional 4,284 shares during the last quarter.

Several brokerages have recently issued reports on ATHN. Morgan Stanley reissued an “equal weight” rating and issued a $125.00 target price (up previously from $108.00) on shares of athenahealth in a research report on Wednesday, August 2nd. SunTrust Banks, Inc. reissued a “buy” rating and issued a $170.00 target price (up previously from $150.00) on shares of athenahealth in a research report on Wednesday, August 2nd. BidaskClub lowered athenahealth from a “hold” rating to a “sell” rating in a research report on Tuesday, August 1st. Cowen and Company lowered athenahealth from an “outperform” rating to a “market perform” rating and increased their target price for the stock from $127.00 to $133.00 in a research report on Monday, July 31st. Finally, ValuEngine raised athenahealth from a “sell” rating to a “hold” rating in a research report on Monday, July 24th. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and thirteen have assigned a buy rating to the company’s stock. athenahealth has an average rating of “Hold” and a consensus price target of $148.64.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Insider Buying and Selling by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.